Contact // the desk
Contact RxTA1: the Thymosin Alpha-1 editorial desk
For editorial questions, corrections, and source suggestions about our Thymosin Alpha-1 coverage.
Get in touch
RxTA1 is an independent editorial digest of the Thymosin Alpha-1 research literature. If you've spotted an error, have a peer-reviewed source we should cover, or want to flag a study we've missed, the form below reaches the editorial desk. Accuracy matters to us — this compound is widely misreported, and we'd rather fix a mistake than leave it standing.
Please note what we can and can't help with, below, before you write.
What we can and can't help with
We can help with: corrections to our summaries, suggestions for peer-reviewed studies to add, questions about how we read a particular finding, and notes on clarity or accuracy.
We can't help with: medical advice, dosing guidance, or treatment decisions — we are not clinicians, and nothing here is a recommendation. We also can't help you buy, source, or obtain the peptide: we don't sell it, don't supply it, and don't refer to vendors. For anything health-related, please consult a qualified clinician who knows your situation. Thymosin Alpha-1 is not FDA-approved in the United States, and questions about its appropriateness for any individual are medical questions, not editorial ones.